Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,150 | -9,430 | -3,190 | -6,540 | -7,180 |
| Depreciation Amortization | 40 | 60 | 60 | 80 | 80 |
| Other Working Capital | -2,260 | 2,910 | -5,830 | 290 | 590 |
| Other Operating Activity | 710 | 980 | 2,210 | 50 | 180 |
| Operating Cash Flow | $-4,660 | $-5,480 | $-6,750 | $-6,120 | $-6,330 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -5 | -90 | -20 | -20 |
| Other Investing Activity | 11 | 4,945 | -5,140 | -90 | -40 |
| Investing Cash Flow | $9 | $4,940 | $-5,230 | $-110 | $-60 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,650 | 1,080 | 8,300 | 0 | 9,490 |
| Financing Cash Flow | $3,650 | $1,080 | $8,300 | $0 | $9,490 |
| Beginning Cash Position | 1,310 | 770 | 4,460 | 10,700 | 7,600 |
| End Cash Position | 310 | 1,310 | 770 | 4,460 | 10,700 |
| Net Cash Flow | $-1,000 | $540 | $-3,690 | $-6,230 | $3,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,660 | -5,480 | -6,750 | -6,120 | -6,330 |
| Free Cash Flow | -4,660 | -5,480 | -6,750 | -6,120 | -6,330 |